國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Immunotherapy of melanoma

Bhandaru, Madhuri.

Immunotherapy of melanoma

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Immunotherapy of melanomaby Anand Rotte, Madhuri Bhandaru.
作者:	Rotte, Anand.
其他作者:	Bhandaru, Madhuri.
出版者:	Cham :Springer International Publishing :2016.
面頁冊數:	xi, 434 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	MelanomaImmunotherapy.
電子資源:	http://dx.doi.org/10.1007/978-3-319-48066-4
ISBN:	9783319480664$q(electronic bk.)

Immunotherapy of melanoma
Rotte, Anand.

Immunotherapy of melanoma[electronic resource] /by Anand Rotte, Madhuri Bhandaru. - Cham :Springer International Publishing :2016. - xi, 434 p. :ill., digital ;24 cm.

Preface -- Melanoma -- Tumor immunology -- Immune based drugs approved for treatment of melanoma -- Promising immunotherapeutic approaches in clinical trials -- Challenges of immunotherapy -- Index.

This book focusses on the different types of immunotherapeutics that are currently being used and developed for the treatment of melanoma. In recent years, immunotherapy has revolutionized the treatment of metastatic melanoma and other types of cancer. Discussing treatment options for melanoma and the success of immunotherapy along with the challenges of immunotherapy, this book covers epidemiology, susceptibility genes, and treatment recommendations from Society for Immunotherapy of Cancer, as well as immune based therapies such as aldesleukin, Intron-A, Sylatron, Yervoy, Opdivo, Keytruda, Imlygic, DC vaccines and adoptive cell therapy. The detailed information included on the key immune cells involved in anti-tumor immune response and immune-inhibitory mechanisms in tumor microenvironment will aid the understanding of tumor immunology. Both academic as well as industry-based researchers, developing novel anti-cancer therapies, will also benefit from the details of promising molecular targets and immunotherapeutic strategies under investigation. With 132 illustrations including synopsis tables for important information, over 1200 references (majority of which are openly accessible) and details of more than 150 ongoing clinical trials, this book is a valuable source of information for health care providers as well as cancer biologists interested in learning about melanoma and the significant advances made by immunotherapy.

ISBN: 9783319480664$q(electronic bk.)

Standard No.: 10.1007/978-3-319-48066-4doiSubjects--Topical Terms:

764176
Melanoma
--Immunotherapy.

LC Class. No.: RC280.M37

Dewey Class. No.: 616.9947706

Immunotherapy of melanoma
LDR:02575nmm a2200313 a 4500 001 500912
003 DE-He213
005 20161221090658.0
006 m d
007 cr nn 008maaau
008 170718s2016 gw s 0 eng d
020 $a 9783319480664$q(electronic bk.)
020 $a 9783319480657$q(paper)
024 7 $a 10.1007/978-3-319-48066-4 $2 doi
035 $a 978-3-319-48066-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.M37
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.9947706 $2 23
090 $a RC280.M37 $b R851 2016
100 1 $a Rotte, Anand. $3 764174
245 1 0 $a Immunotherapy of melanoma $h [electronic resource] / $c by Anand Rotte, Madhuri Bhandaru.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xi, 434 p. : $b ill., digital ; $c 24 cm.
505 0 $a Preface -- Melanoma -- Tumor immunology -- Immune based drugs approved for treatment of melanoma -- Promising immunotherapeutic approaches in clinical trials -- Challenges of immunotherapy -- Index.
520 $a This book focusses on the different types of immunotherapeutics that are currently being used and developed for the treatment of melanoma. In recent years, immunotherapy has revolutionized the treatment of metastatic melanoma and other types of cancer. Discussing treatment options for melanoma and the success of immunotherapy along with the challenges of immunotherapy, this book covers epidemiology, susceptibility genes, and treatment recommendations from Society for Immunotherapy of Cancer, as well as immune based therapies such as aldesleukin, Intron-A, Sylatron, Yervoy, Opdivo, Keytruda, Imlygic, DC vaccines and adoptive cell therapy. The detailed information included on the key immune cells involved in anti-tumor immune response and immune-inhibitory mechanisms in tumor microenvironment will aid the understanding of tumor immunology. Both academic as well as industry-based researchers, developing novel anti-cancer therapies, will also benefit from the details of promising molecular targets and immunotherapeutic strategies under investigation. With 132 illustrations including synopsis tables for important information, over 1200 references (majority of which are openly accessible) and details of more than 150 ongoing clinical trials, this book is a valuable source of information for health care providers as well as cancer biologists interested in learning about melanoma and the significant advances made by immunotherapy.
650 0 $a Melanoma $x Immunotherapy. $3 764176
650 0 $a Melanoma $x Immunological aspects. $3 764177
650 0 $a Medicine. $3 193819
650 0 $a Cancer $x Research. $3 341951
650 0 $a Oncology. $3 195181
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Cancer Research. $3 273660
700 1 $a Bhandaru, Madhuri. $3 764175
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-48066-4
950 $a Biomedical and Life Sciences (Springer-11642)